4th Quarter - Report

MEDLINE for MEDLINE

Firm
Client
Income
—
Expenses
$250,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Healthcare supply chain and resiliency

LobbyistCovered position, as disclosed
AARON ROSS WINTERS —

Contacted: Food & Drug Administration (FDA); White House Office; Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE

Health Issues HCR

Healthcare supply chain and resiliency

LobbyistCovered position, as disclosed
AARON ROSS WINTERS —

Contacted: Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); White House Office

Environment/Superfund ENV

Medical device sterilization

LobbyistCovered position, as disclosed
AARON ROSS WINTERS —

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE; White House Office

Tariff (miscellaneous tariff bills) TAR

Section 301 tariffs, exclusions and compliance, S. 1260 United States Innovation and Competition Act of 2021 concerning Section 301 tariffs

LobbyistCovered position, as disclosed
AARON ROSS WINTERS —

Contacted: U.S. Trade Representative (USTR); White House Office; Health & Human Services, Dept of (HHS); SENATE; Environmental Protection Agency (EPA); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 1260 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.